Stanford researchers have designed a remote digital health platform to assist diagnosis and management of some inflammatory skin conditions, such as eczema.
Stanford researchers have applied large-scale proteomic platforms to identify biomarkers that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status.